Breast Cancer Clinical Trial

Using Diagnostic Tools to Stage Breast Cancer

Summary

This project is aimed at investigating the relative diagnostic and synergy of four state of the art breast imaging techniques (magnetic resonance imaging (MRI), full-field digital mammography (DMAM), ultrasound, and positron emission tomography (PET)) with respect to determining the extent of breast cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Women recently diagnosed with Breast Cancer
Will be undergoing surgery (after study) at the Hospital of the University of Pennsylvania

Exclusion Criteria:

Contraindications to MRI
previously diagnosed with breast cancer (in the smae breast) within the past 5 years
Patients with known locally advanced cancer (prior to study entry) being treated with preoperative adjuvant therapy.
Pregnant women

Study is for people with:

Breast Cancer

Estimated Enrollment:

400

Study ID:

NCT00367666

Recruitment Status:

Active, not recruiting

Sponsor:

University of Pennsylvania

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Pennsylvania
Philadelphia Pennsylvania, 19104, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

400

Study ID:

NCT00367666

Recruitment Status:

Active, not recruiting

Sponsor:


University of Pennsylvania

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider